{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:48:52Z","timestamp":1771364932728,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s13312-017-1209-9","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T05:00:11Z","timestamp":1514955611000},"page":"1041-1046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A new combined vaccine against measles, mumps, rubella and varicella in India"],"prefix":"10.1007","volume":"54","author":[{"given":"Nitin","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raunak","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Casabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafi","family":"Kolhapure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"1209_CR1","unstructured":"World Health Organisation. Mumps Virus Vaccines: WHO Position Paper. Wkly Epidemiol Rec. 2007;82:51-60."},{"key":"1209_CR2","unstructured":"World Health Organisation. Measles Vaccines: WHO Position Paper. Wkly Epidemiol Rec. 2009;84:349-60."},{"key":"1209_CR3","unstructured":"World Health Organisation. Rubella Vaccines: WHO Position Paper. Wkly Epidemiol Rec. 2011;86:301-16."},{"key":"1209_CR4","unstructured":"World Health Organisation. Varicella and Herpes zoster Vaccines: WHO Position Paper. Wkly Epidemiol Rec. 2014;89:265-87."},{"key":"1209_CR5","unstructured":"Historic Dates and Events Related to Vaccines and Immunization. Available from: http:\/\/www.immunize.org\/timeline\/. Accessed July 18, 2016."},{"key":"1209_CR6","unstructured":"World Health Organization. Global Measles and Rubella Strategic Plan, 2012\u20132020. Geneva; WHO 2012. Available from:http:\/\/www.who.int\/immunization\/documents\/control\/ISBN_978_92_4_150339_6. Accessed July 18, 2016."},{"key":"1209_CR7","unstructured":"IAP Immunization Timetable 2016. Available from: http:\/\/www.iapindia.org\/page.php?id=129. Accessed April 13, 2017."},{"key":"1209_CR8","first-page":"993","volume":"46","author":"JL Mathew","year":"2009","unstructured":"Mathew JL. Evidence-based options to improve routine immunization. Indian Pediatr. 2009;46:993\u20136.","journal-title":"Indian Pediatr."},{"key":"1209_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","volume":"26","author":"GS Marshall","year":"2007","unstructured":"Marshall GS, Happe LE, Lunacsek OE, Szymanski MD, Woods CR, Zahn M, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26:496\u2013500.","journal-title":"Pediatr Infect Dis J."},{"key":"1209_CR10","doi-asserted-by":"publisher","first-page":"e1721","DOI":"10.1097\/MD.0000000000001721","volume":"94","author":"SJ Ma","year":"2015","unstructured":"Ma SJ, Li X, Xiong YQ, Yao AL, Chen Q. Combination measles-mumps-rubella-varicella vaccine in healthy children: A systematic review and meta-analysis of immunogenicity and safety. Medicine. 2015;94:e1721.","journal-title":"Medicine."},{"key":"1209_CR11","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","volume":"27","author":"H Czajka","year":"2009","unstructured":"Czajka H, Schuster V, Zepp F, Esposito S, Douha M, Willems P. A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): Immunogenicity and safety profile. Vaccine. 2009;27:6504\u201311.","journal-title":"Vaccine."},{"key":"1209_CR12","unstructured":"Priorix Tetra Full Prescribing Information Version PRT\/PI\/IN\/2017\/02. Available from: GlaxoSmithKline Pharmaceuticals Ltd Dr. Annie Besant Road, Worli, Mumbai-400030 (India)."},{"key":"1209_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00431-010-1142-6","volume":"169","author":"M Knuf","year":"2010","unstructured":"Knuf M, Zepp F, Meyer CU, Habermehl P, Maurer L, Burow HM, et al. Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months. Eur J Pediatr. 2010;169:925\u201333.","journal-title":"Eur J Pediatr."},{"key":"1209_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","volume":"27","author":"V Schuster","year":"2008","unstructured":"Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, et al. Immunogenicity and safety assessments after one and two doses of a refrigeratorstable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J. 2008;27:724\u201330.","journal-title":"Pediatr Infect Dis J."},{"key":"1209_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","volume":"25","author":"M Knuf","year":"2006","unstructured":"Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, et al. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J. 2006;25:12\u20138.","journal-title":"Pediatr Infect Dis J."},{"key":"1209_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","volume":"171","author":"M Knuf","year":"2012","unstructured":"Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, et al. Antibody persistence for 3 years following two doses of tetravalent measles-mumpsrubella-varicella vaccine in healthy children. Eur J Pediatr. 2012;171:463\u201370.","journal-title":"Eur J Pediatr."},{"key":"1209_CR17","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.vaccine.2009.02.044","volume":"27","author":"SA Halperin","year":"2009","unstructured":"Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, et al. Safety and immunogenicity of a measlesmumps-rubella-varicella vaccine given as a second dose in children up to six years of age. Vaccine. 2009;27:2701\u20136.","journal-title":"Vaccine."},{"key":"1209_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.vaccine.2008.10.064","volume":"27","author":"Y Gillet","year":"2009","unstructured":"Gillet Y, Steri GC, Behre U, Arsene JP, Lanse X, Helm K, et al. Immunogenicity and safety of measles-mumpsrubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine. Vaccine. 2009;27:446\u201353.","journal-title":"Vaccine."},{"key":"1209_CR19","doi-asserted-by":"publisher","first-page":"e007202","DOI":"10.1136\/bmjopen-2014-007202","volume":"5","author":"S Lalwani","year":"2015","unstructured":"Lalwani S, Chatterjee S, Balasubramanian S, Bavdekar A, Mehta S, Datta S, et al. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumpsrubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial. BMJ Open. 2015;5:e007202.","journal-title":"BMJ Open."},{"key":"1209_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","volume":"383","author":"R Prymula","year":"2014","unstructured":"Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383:1313\u201324.","journal-title":"Lancet."},{"key":"1209_CR21","unstructured":"Czajka H, Brzostek J, Gabutti G, Gasparini R, Desole MG, Pazdiora P, et al. Comparison of six year efficacy between one or two doses of live varicella virus-containing vaccines: a randomized, placebo-controlled trial. Presented at European Society for Paediatric Infectious Diseases -33rd Annual Meeting. 12-16 May 2015; Leipzig Germany: ESPID-0644."},{"key":"1209_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","volume":"28","author":"M Spackova","year":"2010","unstructured":"Spackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, Heininger U, Siedler A. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28:686\u201391.","journal-title":"Vaccine."},{"key":"1209_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2165\/00148581-200810050-00007","volume":"10","author":"S Dhillon","year":"2008","unstructured":"Dhillon S, Curran MP. Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra). Paediatr Drugs. 2008;10:337\u201347.","journal-title":"Paediatr Drugs."},{"key":"1209_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","volume":"32","author":"T Schink","year":"2014","unstructured":"Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine. 2014;32:645\u201350.","journal-title":"Vaccine."},{"key":"1209_CR25","unstructured":"Hense S, Schink T, Garbe E. 2nd immunization against measles, mumps, rubella with MMRV, MMR or MMR+V in Germany and risk of febrile convulsions. Presented at International Society for Pharmacoepidemiology -29th International Conference. 25-28 August 2013; Montreal, Canada: ID24."},{"key":"1209_CR26","first-page":"1","volume":"59","author":"M Marin","year":"2010","unstructured":"Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and Reports. 2010;59:1\u201312.","journal-title":"MMWR. Recommendations and Reports."},{"key":"1209_CR27","unstructured":"Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute\u20132016\/ 2017. Epidemiologisches Bulletin. 2016;34:301-38."},{"key":"1209_CR28","unstructured":"Measles, Mumps, Rubella, Varicella Vaccine -Information for health professionals. Available from: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/IT0167-cnt\/$File\/final-mmrvprovider-booklet.pdf. Accessed April 21, 2017."},{"key":"1209_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00431-007-0506-z","volume":"166","author":"F Zepp","year":"2007","unstructured":"Zepp F, Behre U, Kindler K, Laakmann KH, Pankow-Culot H, Mannhardt-Laakmann W, et al. Immunogenicity and safety of a tetravalent measles-mumps-rubellavaricella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. Eur J Pediatr. 2007;166:857\u201364.","journal-title":"Eur J Pediatr."},{"key":"1209_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/01.inf.0000207857.10947.1f","volume":"25","author":"H Shinefield","year":"2006","unstructured":"Shinefield H, Black S, Thear M, Coury D, Reisinger K, Rothstein E, et al. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate\/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. Pediatr Infect Dis J. 2006;25:287\u201392.","journal-title":"Pediatr Infect Dis J."},{"key":"1209_CR31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","volume":"29","author":"T Vesikari","year":"2010","unstructured":"Vesikari T, Karvonen A, Lindblad N, Korhonen T, Lommel P, Willems P, et al. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months. Pediatr Infect Dis J. 2010;29:e47\u201356.","journal-title":"Pediatr Infect Dis J."},{"key":"1209_CR32","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1016\/j.vaccine.2011.03.043","volume":"29","author":"T Vesikari","year":"2011","unstructured":"Vesikari T, Karvonen A, Bianco V, Van der Wielen M, Miller J. Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumpsrubella-varicella vaccine during the second year of life: An open, randomized controlled trial. Vaccine. 2011;29: 4274\u201384.","journal-title":"Vaccine."}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-017-1209-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-017-1209-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-017-1209-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:25:51Z","timestamp":1659097551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-017-1209-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1209"],"URL":"https:\/\/doi.org\/10.1007\/s13312-017-1209-9","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"4 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}